HSBC restated its 'hold' rating on CVS Health, while Manufacturers Life Insurance Company increased its stake in the company's shares.
1 report, 1 independent
Updated Sep 12
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
HSBC restated its 'hold' rating on CVS Health, while Manufacturers Life Insurance Company increased its stake in the company's shares.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
HSBC
British multinational bank
-
CVS Health
company
-
Manufacturers Life Insurance Company
business
Related events
- CVS Health and Invesco were identified as top dividend stocks in a 2025 index.
- Oscar Health and CVS Health are identified as health insurance providers in the market segment.
- HSBC reaffirmed a hold rating on Lam Research on August 30, 2026.
- Larry Robbins sold CVS Health shares, and Fifth Third Bancorp lifted its position in CVS Health stock, both disclosed to the SEC.
- ARS Pharmaceuticals Inc. was reported for misleading investors about its coverage progress.